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Abstract
Background: The underlying molecular processes representing stress responses to low-dose ionising radiation
(LDIR) in mammals are just beginning to be understood. In particular, LDIR effects on the brain and their possible
association with neurodegenerative disease are currently being explored using omics technologies.
Results: We describe a light-weight approach for the storage, analysis and distribution of relevant LDIR omics
datasets. The data integration platform, called BRIDE, contains information from the literature as well as
experimental information from transcriptomics and proteomics studies. It deploys a hybrid, distributed solution
using both local storage and cloud technology.
Conclusions: BRIDE can act as a knowledge broker for LDIR researchers, to facilitate molecular research on the
systems biology of LDIR response in mammals. Its flexible design can capture a range of experimental information
for genomics, epigenomics, transcriptomics, and proteomics. The data collection is available at:
<bride.azurewebsites.net>.
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Background
In recent years, industrial societies have experienced a
significant increase of exposure to low-dose ionising
radiation (LDIR), with possible implications for human
health and disease [1]. The known causes of LDIR
exposure typically arise from advanced medical diag-
nostic procedures [2], air travel [3] and nuclear industry
incidents, including the major Chernobyl [4] and
Fukushima [5] disasters. Other effects might involve
specific population groups, for instance health profes-
sionals with frequent exposure to ionising radiation or
space travelers [6]. Examples of acute doses that motiv-
ate much of LDIR research include medical diagnostic
procedures or radiotherapy treatment. It is estimated
that, in total, the annual increase to LDIR exposure has
dramatically risen on average from 0.5 mSv in 1980 to
3 mSv today, particularly in the industrial world [7].
This general trend stipulates the intensification of
research on LDIR effects on health – both chronic and
acute [8], in particular the understanding of molecular
mechanisms involved with a view to radiation protec-
tion as well as the mitigation of those effects by policies
or precautionary measures at low- or even moderate-
ionising radiation doses [9].
Since the early days of LDIR research, questions
regarding health effects at the molecular and system
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levels have been raised [10–12]. Early studies with
variable doses concentrated on certain tissues, e.g. skin
[13] or bone [14] and molecules, e.g. thioredoxins [15].
Subsequently, comparisons between normal and neo-
plastic cell lines [16] and studies of cellular processes
such as apoptosis [17] have contributed towards a deeper
appreciation of the complex responses to LDIR, with
implications for human health [18] or specific situations,
e.g. air [3] or space [19] travel.
Despite significant progress, it was not until a decade
ago that a better understanding has emerged with regard
to the underlying molecular processes involved in the
LDIR response [20]. The most pertinent studies have
highlighted those effects with low dose for skin [21]
and higher doses for the cardiovascular system [22, 23]
– first recorded in tissue culture and later as models
for human physiology at the whole-tissue level. The
genome-wide quest for reliable biomarker molecules
for radiation exposure has been instigated recently [24,
25], with focus on individual molecules [26, 27], proteo-
mics at high [28, 29] or low [30, 31] doses, and ex-
pression studies [32–34] or particular conditions, for
example effects on neurodegenerative disease [35, 36].
To our knowledge, the lowest doses ever published for
radiation effects involve 20 mGy for mouse heart [37]
and liver [38].
While LDIR effects for skin or heart have been ex-
tensively recognized, very little is currently known for
their action in the cerebrovascular system and the
brain [9, 39]. To access this black box of human physi-
ology, integrated approaches with mouse models and
molecular, cellular, organismal, behavioral, and epidemio-
logical components are becoming vital [40]. These com-
plex data landscapes need to be organized and analyzed
using proper data integration platforms – by merging rele-
vant databases, experimental resources, analytical tools
and systems biology [41].
Construction and content
Data integration requirements
In our efforts to record and analyze relevant experimental
and computational information for LDIR effects on the
brain, we have taken a light-weight approach to data
integration [42]. Previously, several approaches have
attempted to address critical bottlenecks in the integration
of complex biological data, such as disregard of commonly
accepted data standards, variable user interfaces, lack of
collaborative spaces, immature data exchange services and
time consuming pipelines for advanced bioinformatics
analysis [43]. The continuing increase of data volumes
creates additional obstacles in both processing and ana-
lysis. The concept of big data combined with cloud
services [44] provides a direction for new solutions to the
above mentioned challenges.
There are several ways of achieving integration be-
tween data resources, including biological databases
and lab data collections. First, the data warehouse
concept proposes the creation of a local data repository
to facilitate queries executed locally; second, the single-
database engine approach offers more efficient access
via queries, which however need to be executed locally
using full indexing; third, hypertext link integration
provides opportunities for less structured collections,
with the predictable drawback of complex data naviga-
tion [45]. The rise of web technologies contributes
towards the development of new protocols and plat-
forms called Web Services that maintain a middle ground
between the above options, in order to exchange data
between different data resources or systems. Typical
examples of such approaches are based on Service-
Oriented Architectures (SOAs) [46] or REpresentational
State Transfer (REST) [47].
In our work, the integration of data resources in the con-
text of LDIR research presented two challenges: first, to
assemble relevant publicly available omics data – including
transcriptomics and proteomics for a number of conditions,
tissues and phenotypes under consideration, and second, to
include novel experimental data from collaborating
laboratories within a framework that will lead to mo-
lecular systems biology-based pathway inference and
biomarker discovery. Thus, the high-level requirements
for data integration in LDIR research in non-technical
language are: the recording of the identity of relevant
molecules (i.e. with sequence identifiers), the quality
control of the imported data from the literature and
own experiments, and the secure transfer and access of
those data by partner laboratories and researchers, as
well as a public access portal.
In line with the primary aims and the four high-level
requirements mentioned above, we have developed a plat-
form for LDIR research called BRIDE. BRIDE provides
access to a number of tasks displayed as tabs for users,
including editing gene lists and tools, while implementing
light-weight integration with a number of hand-picked,
relevant web services for computational systems biology,
including genomics, transcriptomics, proteomics and
phenotype data resources [41].
We have thus combined results recorded from an
exhaustive analysis of the existing literature with our
own experimental results. We have created ‘unification
links’ connecting molecules with their corresponding
database entries and ‘relationship links’ connecting mole-
cules with their biological context [48], associating them
with co-expressed genes, protein interactions or cellular
pathways [49]. BRIDE supports access via a web browser
client [50]. This type of integration is called navigational
or link-based, and can be ideal for development efforts
with modest resources [45].
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System architecture
The BRIDE platform implementation is based on the
Microsoft® (MS®) computational ecosystem. According to
our extensive research at the early development phase,
there are several examples with successful implementa-
tions of bioinformatics projects using MS® solutions [51].
Thus, we have decided to implement a scalable, robust,
industry-strength solution for BRIDE. The development
was attained with Visual Studio 2012 [52], using in par-
ticular the LightSwitch tool. From the architectural point
of view, the BRIDE platform is a browser client, 3-tier
system [53]. This deployment scenario creates an applica-
tion that runs via the end-user’s web browser. The data-
base and server components run on a database server,
running on web MS® IIS server.
The LightSwitch component executes widely-used
MS® technologies and patterns like Entity Framework for
data access, n-tier application layers and Model-View-
View-Model (MVVM) [54]. This type of architecture
allows for any system component to be modified without
having to change the other two parts of the 3-tier
architecture, therefore facilitating maintenance and re-
sponse to changes. The tiers of the platform communicate
through interfaces. Therefore, as long as the interface
remains stable, the internals can change without affecting
the rest of the platform.
With 3-tier applications, the business rules1 and queries
are removed from the client and are executed on a system
between the user interface (e.g. client browser) and the
data storage system (in this case, the MS® SQL database).
The client application provides a standard user interface
or a presentation layer for the platform. The business rules
server ensures that all of the business processing and
queries is executed properly, and serves as an intermedi-
ary between the client and the data storage layers. Note
that, in this type of application, the client does not access
the data storage system directly. The final deployment is
based on a MS® platform: local servers run the Windows®
2008 R2 Server operating system, FTP server, MS® SQL
2012 Server relational database management system and
MS® Azure cloud services and can be replicated at other
sites (Fig. 1). According to our usage pattern, planning the
hybrid cloud solution fits optimally to our needs: this solu-
tion ensures data security, with the database hosted lo-
cally, while the presentation layer or the web site is hosted
on the cloud. The main benefits for the cloud-based
services are lower costs, a significant decrease in develop-
ment time and low system administration workloads.
Fig. 1 BRIDE system architecture. The 3-tier architecture between storage, processing and presentation
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The steps in the data preparation process were as
follows: (i) partner laboratories submitted their experi-
mental results to the BRIDE storage site via a secure
FTP server – accepted formats are MS® Excel files or
tab-delimited text files. The recommended fields were:
gene name (used from the corresponding reference
genome), organism (mouse in this case), tissue (brain or
other tissues), time after irradiation, radiation dose
(metadata) and lab (identification); (ii) using Google
Refine [55], an open source power tool for cleaning large
data sets, we were able to convey and store data, using
http requests and stripping techniques, and (iii) subse-
quently enrich the submitted collections with identifica-
tion names from different resources – e.g. UniProt protein
identifiers [56] based on gene names; (iv) the final table is
exported to MS® SQL production database; (v) finally, we
have generated all ‘unification’ links using SQL store
procedures. The data preparation stage offered a seamless
pipeline to prepare the data for submission. Using
SQL store procedures, it is easy to update links in
case a data provider issues any alterations to their
web-services definitions.
Data consumption
End users are thus able to access all BRIDE data at two
different levels: (i) Users can access a fully searchable
gene catalog via their browser, through unification or
relationship links. ‘Unification links’ connect gene entries
with their corresponding database records [48]. We have
also managed to integrate data contents from NCBI
resources [57], the IntAct protein interaction database
[58], the Allen Brain Atlas [59] and Rb-STORE
(www.rbstore.eu/) into BRIDE, with a view to continue
capturing information from molecular resources against
a rich backdrop of phenotypic features relevant to sys-
tems radiobiology, as needs arise (Fig. 2). The links
within BRIDE, and across data resources, were built
using the available REST APIs, which are distinct for
each data repository. The corresponding actions (input/
output) for unification links are listed in Table 1. ‘Rela-
tionship links’ connect molecules with their local bio-
logical context, as mentioned above [48]. Users may
select more than one molecule and search for their re-
spective pathways using the PCViz component of the
PathwayCommons resource [60], accessible at
<pathwaycommons.org/pcviz/>.
(ii) The second method available for BRIDE data
consumption is based on the MS® Open Data (OData)
technical protocol [61]. OData defines an abstract data
model allowing different clients to access those data
programmatically. OData builds on AtomPub, an ab-
stract implementation of a REST design pattern, ignor-
ing some of the REST constraints in the process. OData
services require URIs construction to enable the proto-
col querying capability and returns results in XML
(Fig. 3) or JSON formats [62]. The benefit of this proto-
col implementation is that users can access data in a
high-throughput mode or use tools like the MS® Excel
Fig. 2 BRIDE gene catalog. A detailed screenshot of BRIDE’s gene catalog, with entities described
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Table 1 BRIDE integration with data resources
Provider Section Type Results
NCBI Graph Unification Link web page
Fasta Unification Link web page
Biosystems Unification Link web page
Pathway Unification Link web page
Protein Unification Link web page
Geo Profile Unification Link web page
PIE Unification Link web page
EMBL-EBI IntAct Cytoscape Graph Unification Link cytoscape file
Ch EBI Ontology Browser Unification Link web page
GO Ontology Browser Unification Link web page
Taxonomy Browser Unification Link web page
Interactions Unification Link web page
Rb Store Organism Unification Link web page
Tissue Unification Link web page
Allen Mouse Brain Mouse Brain Experiments Unification Link web page
Developing Mouse Brain Experiments Unification Link web page
Expression Mask Image Unification Link image file
PCViz Pathway Commons Network Visualizer Relationship Link web page
Fig. 3 OData XML results. Example results in XML format
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plugin Pivot, in order to import data and proceed to further
analysis locally – e.g. by including those data into the
popular Ingenuity® suite.
To achieve the above goals following the specified user
requirements, in particular to provide a systems biology
context for the LDIR response at the molecular level,
one needs to first identify the molecules under consider-
ation and second to understand their interactions with
other molecules at different levels of expression. Coupled
with the experimental efforts within the CEREBRAD
project for transcriptomics and proteomics, we plan to
explore this landscape of relevant molecules and interac-
tions to better understand LDIR response in the brain
(manuscript in preparation).
Data contents
Currently, the BRIDE collection contains 3,174 relevant
records defined uniquely by the tuple: ‘tissue-dose-time
(after irradiation)’. The majority of these entries (3,016,
or 95 %) correspond to protein-coding genes detected
in the mouse brain, according to the original studies
(recorded as PubMed identifiers – PMIDs) – this does
not necessarily mean that they are brain-specific. A
small minority of proteins are found in other tissues as
well, and have been included due to their mentions in
the same experimental recordings. These entries might
further be used as controls in brain studies – for in-
stance, inclusion of those entries in future brain-related
studies. Most records are compiled from four publica-
tions associated with the CEREBRAD project, referred
again by their PMID numbers, 3009 in total (or 95 %):
more precisely, 533 [35], 182 [63], 1828 [64], 312 [65]
and another 154 unpublished instances. The remaining
165 instances have been recorded manually by scanning
over hundreds of relevant articles in the literature, and
selecting six additional publicatoins – their PMIDs are
also provided [28, 29, 49, 66–69]. For all these gene
entries, unification and relationship links were gener-
ated, where possible. Averaging ~18 links per molecule
(Table 1), we have >55,000 links at our disposal. Thus,
the corpus of data within BRIDE is extremely rich as
well as challenging to explore, for pathway inference in
the context of radiation effects on the brain, e.g. cogni-
tive deficits in adult, prenatally exposed mice [70, 71].
These links also provide critical histology and other
experimental evidence for the involvement of the corre-
sponding genes in brain function, e.g. the Allen Mouse
Brain Atlas.
The other two elements defining uniqueness of the
recorded entries in the BRIDE data collection, namely
dosimetry and time, are less uniform thus reflecting a wide
range of experimental designs or conditions (Table 2): for
instance, 48 % of records refer to doses <1 Gy while 46 %
of records have been observed at more than 5 weeks since
irradiation. A small number (133 in total) of entries were
not assigned to a specific dosimetry-time as these obser-
vations came from the scanner literature, with unclear
experimental details (but are recorded for completess and
can be filtered out).
Utility and discussion
The BRIDE platform is an easy-to-use resource with a
clean design, modest development efforts, and wider
applicability in radiobiology research that supports
our joint efforts and distributes the obtained results
to the wider community. We have primarily taken a
gene/protein-oriented approach with the view that a
genome browser-like design would be both labor-
intensive and of unclear relevance at this exploratory
phase of LDIR response. Database development and
implementation have been based on modern software
technologies and protocols. The fundamental design
principles were platform usability and portal access,
which expand data consumption options available to
end users. We have thus minimized the effort of
platform management by utilizing a hybrid cloud de-
ployment method. The automated data preparation
pipeline currently allows scientists to focus on their
studies and not wrangle with data formats. Finally,
Uniform resource identifier (URI) integration links are
easily updated in case of web service modifications by
data providers. Further integration with other parallel
efforts, such as Radiation Genes [72] or NIF [73],
might be possible in the future.
Table 2 Dose and Time statistics for all records in the BRIDE data collection
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Conclusion
The BRIDE platform can act as a knowledge broker for
LDIR researchers, to cope with the ever-increasing
amounts of data, their heterogeneous nature, the varying
landscape of data types and formats, and the expanding
resources for genomics, epigenomics, transcriptomics,
and proteomics in LDIR research – as well as a commu-
nity data portal. As the project evolves, we will understand
better the requirements and improve the peer-to-peer
communication of scientific results between stakeholders,
with the aspiration that BRIDE is used widely by the LDIR
community and beyond [74]. While we are still in the
process of analyzing these results and other omics aspects
of LDIR response (manuscript in preparation), the BRIDE
data integration platform design already allows direct use
and design modifications that can capture additional types
of information from next-generation sequencing (NGS),
as well as epigenomics and behavioral data.
Availability and requirements
The BRIDE platform can be accessed with a web browser
at <bride.azurewebsites.net>.
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